CareLit · DOI-Nachweis · Zeitschrift für Gastroenterologie
Improvement of sustained virologic response (SVR) in the treatment of genotype 1 infected male patients with PEG-INFα-2b by ribavirin dose adjustments
DOI 10.1055/s-0030-1263895
Bibliografische Angaben
Nachweis in CareLit
Autor:innenS Mauss, E Zehnter, MP Manns, G Teuber, T Dahhan, U Meyer, T Witthöft, B Möller, N Dikopoulos, J Brack, M Bilzer, G Tossing, D Hüppe
ZeitschriftZeitschrift für Gastroenterologie
Ausgabe08/2010
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Background and Aims: Two peginterferon (weight-based PEG-INFα-2b and fixed-dose PEG-INFα-2a) and ribavirin regimens approved for HCV treatment were recently compared in the IDEAL study (McHutchison, 2009). While overall SVR rates of patients (pts) infected with genotype 1 (G1) were similar with both regimens a 10% difference was observed for pts weighing 75–85kg. The latter were treated either with PEG-INFα-2b plus…
Zitieren
Zitierempfehlung
S Mauss, E Zehnter, MP Manns, G Teuber, T Dahhan, U Meyer, T Witthöft, B Möller, N Dikopoulos, J Brack, M Bilzer, G Tossing, D Hüppe (2010) Improvement of sustained virologic response (SVR) in the treatment of genotype 1 infected male patients with PEG-INFα-2b by ribavirin dose adjustments. Zeitschrift für Gastroenterologie (08). https://doi.org/10.1055/s-0030-1263895
Mit CareLit weiterarbeiten